The wound care provider filed the suit for allegedly falsifying and misleading consumers with clinical data.
These stocks look ready to break out and trade higher from current levels.
Trade-Ideas LLC identified Osiris Therapeutics (OSIR) as a weak on high relative volume candidate
Cramer says Osiris Therapeutics is exciting, Opko Health is a buy and you can't go wrong with PPG Industries.
©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.